276 related articles for article (PubMed ID: 19409594)
1. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
[TBL] [Abstract][Full Text] [Related]
3. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
4. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
[TBL] [Abstract][Full Text] [Related]
5. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
6. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.
Rodríguez T; Pérez O; Ménager N; Ugrinovic S; Bracho G; Mastroeni P
Vaccine; 2005 Jan; 23(10):1312-21. PubMed ID: 15652674
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
8. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
Diebold SS; Cotten M; Koch N; Zenke M
Gene Ther; 2001 Mar; 8(6):487-93. PubMed ID: 11313828
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity.
Brown M; Zhang Y; Dermine S; de Wynter EA; Hart C; Kitchener H; Stern PL; Skinner MA; Stacey SN
Gene Ther; 2000 Oct; 7(19):1680-9. PubMed ID: 11083477
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation.
Hiasa Y; Takahashi H; Shimizu M; Nuriya H; Tsukiyama-Kohara K; Tanaka T; Horiike N; Onji M; Kohara M
J Med Virol; 2004 Oct; 74(2):253-61. PubMed ID: 15332274
[TBL] [Abstract][Full Text] [Related]
11. Antigen processing: cultured lymph-borne dendritic cells can process and present native protein antigens.
Liu LM; MacPherson GG
Immunology; 1995 Feb; 84(2):241-6. PubMed ID: 7751000
[TBL] [Abstract][Full Text] [Related]
12. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
13. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
14. CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells.
Bevaart L; Van Ojik HH; Sun AW; Sulahian TH; Leusen JH; Weiner GJ; Van De Winkel JG; Van Vugt MJ
Int Immunol; 2004 Aug; 16(8):1091-8. PubMed ID: 15192052
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming.
Klein I; Gassel HJ; Crispe IN
Transplant Proc; 2006 Dec; 38(10):3241-3. PubMed ID: 17175235
[TBL] [Abstract][Full Text] [Related]
16. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.
Pang KC; Wei JQ; Chen W
J Immunol Methods; 2006 Apr; 311(1-2):12-8. PubMed ID: 16516224
[TBL] [Abstract][Full Text] [Related]
17. Self peptide/MHC class I complexes have a negligible effect on the response of some CD8+ T cells to foreign antigen.
Spörri R; Reis e Sousa C
Eur J Immunol; 2002 Nov; 32(11):3161-70. PubMed ID: 12555661
[TBL] [Abstract][Full Text] [Related]
18. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.
Laus R; Graddis TJ; Hakim I; Vidovic D
Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805
[TBL] [Abstract][Full Text] [Related]
19. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
Chen L; Jondal M
Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
[TBL] [Abstract][Full Text] [Related]
20. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.
Shastri N; Gonzalez F
J Immunol; 1993 Apr; 150(7):2724-36. PubMed ID: 8454852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
